4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001209191-19-052238
Options or other derivatives
- Director acquired 15,352 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Aldag Jorn Director | 2019-10-01 | Grant or award · Stock Option (Right to Buy) | +15,352 | $0.88 | $13,501 | 15,352 | D |
Loading xslF345X03/doc4.xml…